Alzahrani AS - Search Results

1

Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.

Alzahrani AS, Qasem E, Murugan AK, Al-Hindi HN, AlKhafaji D, Almohanna M, Xing M, Alhomaidah D, AlSwailem M. Alzahrani AS, et al. Thyroid. 2016 Feb;26(2):235-41. doi: 10.1089/thy.2015.0510. Epub 2016 Jan 21. Thyroid. 2016. PMID: 26711586

2

Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

Binyousef HM, Alzahrani AS, Al-Sobhi SS, Al SH, Chaudhari MA, Raef HM. Binyousef HM, et al. Among authors: alzahrani as. World J Surg. 2004 Nov;28(11):1110-4. doi: 10.1007/s00268-004-7636-5. World J Surg. 2004. PMID: 15490054

3

High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.

Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Abu-Amero KK, et al. Among authors: alzahrani as. Oncogene. 2005 Feb 17;24(8):1455-60. doi: 10.1038/sj.onc.1208292. Oncogene. 2005. PMID: 15608681

4

Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.

Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. Abu-Amero KK, et al. Among authors: alzahrani as. Oncogene. 2006 Feb 2;25(5):677-84. doi: 10.1038/sj.onc.1209094. Oncogene. 2006. PMID: 16205644

5

Diagnostic accuracy of high-resolution neck ultrasonography in the follow-up of differentiated thyroid cancer: a prospective study.

Alzahrani AS, Alsuhaibani H, Salam SA, Al Sifri SN, Mohamed G, Al Sobhi S, Sulaiman O, Akhtar M. Alzahrani AS, et al. Endocr Pract. 2005 May-Jun;11(3):165-71. doi: 10.4158/EP.11.3.165. Endocr Pract. 2005. PMID: 16239202 Clinical Trial.

6

Role of [18F]fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer.

Alzahrani AS, Mohamed GE, Al Rifai A, Al-Sugair A, Abdel Salam SA, Sulaiman OM, Demirkaya O. Alzahrani AS, et al. Endocr Pract. 2006 Mar-Apr;12(2):152-8. doi: 10.4158/EP.12.2.152. Endocr Pract. 2006. PMID: 16690462

7

Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

Zou M, Baitei EY, Alzahrani AS, Al-Mohanna F, Farid NR, Meyer B, Shi Y. Zou M, et al. Among authors: alzahrani as. Neoplasia. 2009 Jan;11(1):57-65. doi: 10.1593/neo.81044. Neoplasia. 2009. PMID: 19107232 Free PMC article.

8

Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.

Baitei EY, Zou M, Al-Mohanna F, Collison K, Alzahrani AS, Farid NR, Meyer B, Shi Y. Baitei EY, et al. Among authors: alzahrani as. J Pathol. 2009 Apr;217(5):707-15. doi: 10.1002/path.2496. J Pathol. 2009. PMID: 19156774

9

Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer.

Alshaikh OM, Al-Mahfouz AA, Al-Hindi H, Mahfouz AB, Alzahrani AS. Alshaikh OM, et al. Among authors: alzahrani as. Endocr Pract. 2010 Mar-Apr;16(2):249-54. doi: 10.4158/EP09243.CR. Endocr Pract. 2010. PMID: 20061271

10

Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.

Alzahrani AS, AlQaraawi A, Al Sohaibani F, Almanea H, Abalkhail H. Alzahrani AS, et al. Thyroid. 2012 May;22(5):536-41. doi: 10.1089/thy.2011.0247. Epub 2012 Mar 21. Thyroid. 2012. PMID: 22435913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters